import type { BlogPost } from '../types';
import sabahAlEmaratImage from '../assets/blog Sabah Al Emarat .webp';
import isdsPodiumImage from '../assets/blogs/ISDS/podium.webp';
import isdsPodiumWideImage from '../assets/blogs/ISDS/podium-wide.webp';
import isdsModeratorsImage from '../assets/blogs/ISDS/moderators.webp';
import isdsRecognitionImage from '../assets/blogs/ISDS/session-recognition.webp';
import diabeticFootImage from '../assets/Diabetic Foot blog .webp';
import internationalConferenceImage from '../assets/International Conference Journals.webp';
import successStoryImage from '../assets/Success Story blog .webp';
import botulinumResearchImage from '../assets/blog.webp';
import advanceThreadImage from '../assets/Advance Thread blog .webp';
import ebdTeachingImage from '../assets/EBD Teaching blog. (2).webp';
import ebdTeachingImage2 from '../assets/EBD Teaching blog..webp';
import ebdTeachingImage3 from '../assets/EBD Teaching blog.webp';
import americanBoardHero from '../assets/blogs/American Board/hero.webp';
import americanBoardSigning from '../assets/blogs/American Board/img2.webp';
import americanBoardTable from '../assets/blogs/American Board/img3.webp';
import germanUniversityImage from '../assets/blogs/germany/signing.webp';
import germanUniversityImage2 from '../assets/blogs/germany/signing-detail.webp';
import germanUniversityImage3 from '../assets/blogs/germany/team.webp';

export const blogPosts: BlogPost[] = [
  {
    id: 'blog-12',
    slug: 'german-university-scientific-collaboration-agreement',
    title: 'Everlast Signs a Joint Scientific Collaboration Agreement with the German University',
    excerpt: 'On 3 February 2026, Dr. Christeen Youssef led the signing of a joint scientific collaboration agreement between Everlast Wellness Medical Center and the German University — a framework for exchanging knowledge, expertise and best practice in stem cell research and its modern applications in regenerative medicine.',
    date: '03/02/2026',
    category: 'PARTNERSHIP',
    readTime: '2 min',
    image: germanUniversityImage,
    // A portrait phone shot where the ceiling and the air-conditioning grilles
    // take the top half, so the default 32% fills a wide frame with ceiling.
    //
    // The hero anchors at the base, which puts the table, the papers and both
    // signatories in its 78svh frame. The carousel is centred instead: it is a
    // taller frame that also spends its hold scaled up around its own centre,
    // and the two together crop from the top — bottom-anchored there, the drift
    // walks the signatories' heads off the top edge and leaves the tabletop.
    imageFocus: { hero: '50% 100%', carousel: '50% 50%' },
    // The closer signing shot runs beside the section on what the agreement
    // actually covers, breaking out of the measure into the right margin.
    // Squared off and anchored to the base: at its own 3:4 the top third is
    // ceiling and air-conditioning grilles, which is a picture of the room
    // rather than of the signing.
    figures: [
      {
        section: 'research-training-and-therapeutic-protocols',
        image: germanUniversityImage2,
        side: 'right',
        bleed: true,
        crop: 'square',
        focus: '50% 100%',
        alt: 'Dr. Christeen Youssef’s counterparts signing the collaboration agreement at Everlast Wellness Medical Center.',
      },
    ],
    // The group photograph left alone in the band, so it closes the article on
    // the full-width letterbox. Centred rather than anchored: a 21:9 slice of
    // the middle gives all four faces against the centre wall, where the base
    // would give the floor.
    gallery: [germanUniversityImage3],
    content: `On 3 February 2026, Dr. Christeen Youssef led the signing of a landmark scientific collaboration agreement between Everlast Wellness Medical Center and the German University. The partnership establishes a framework for the exchange of scientific knowledge, expertise and best practice in the field of stem cell research and its modern applications in regenerative medicine.

## Research, Training and Therapeutic Protocols

The agreement focuses on collaborative research initiatives, joint training programmes, and the development of innovative therapeutic protocols that carry cutting-edge stem cell technologies into clinical practice. Dr. Christeen highlighted the importance of bridging academic research with practical medical application — so that discoveries in stem cell biology are translated into treatments that are safe and effective for the patient in front of you.

The collaboration also opens the way for faculty and student exchanges, joint workshops and shared publications, so that what is learned moves between international scientific communities rather than staying inside one of them.

## A Regional Hub for Regenerative Medicine

Through this partnership Everlast reinforces its commitment to scientific excellence and innovation, positioning itself as a regional hub for advanced regenerative medicine research. Dr. Christeen emphasised that the collaboration will not only extend the centre’s research capability but also open access to state-of-the-art methodologies, contributing to the development of novel therapies across a range of medical conditions.

## What the Agreement Represents

By combining the strengths of Everlast and the German University, the agreement marks a significant step forward in advancing global stem cell research, improving clinical outcomes, and sustaining international collaboration in a field that is moving quickly. It sets the terms under which the two institutions will work as one research community rather than two that occasionally correspond.`
  },
  {
    id: 'blog-10',
    slug: 'american-board-cooperation-agreement',
    title: 'Everlast Signs a Joint Scientific Research and Training Agreement with the American Board of Education',
    excerpt: 'On 9 February 2026 in Abu Dhabi, Dr. Christeen Youssef led the signing of a joint scientific and educational cooperation agreement between Everlast Wellness Medical Center and the American Board of Education — formalising the centre’s role in research, professional training and the clinical application of modern medical technologies.',
    date: '09/02/2026',
    category: 'PARTNERSHIP',
    readTime: '2 min',
    image: americanBoardHero,
    // Both sit in the column beside the copy, in this order. The signing shot
    // is the portrait of the two, so it takes half the column.
    gallery: [
      { image: americanBoardSigning, width: 'half' },
      americanBoardTable,
    ],
    content: `On 9 February 2026, Dr. Christeen Youssef led the signing of a landmark joint scientific and educational cooperation agreement between Everlast Wellness Medical Center and the American Board of Education in the Emirate of Abu Dhabi. This strategic partnership formalises Everlast’s role in advancing scientific research, professional training, and the implementation of modern medical technologies, creating a robust framework for collaboration between local and international experts.

## Evidence-Based Practice, Applied

Under Dr. Christeen’s leadership, Everlast continues to integrate evidence-based clinical practice with pioneering applications in tissue engineering and regenerative medicine. The centre uses advanced technologies to develop innovative therapies, conduct clinical research, and train medical professionals in the latest protocols — so that practitioners and patients alike benefit from the most current approaches in the field.

## Education, Workshops and Mentorship

The agreement also sets out the centre’s role in education: workshops, seminars and specialised training programmes designed to raise the skills of healthcare professionals in the UAE and beyond. Through knowledge exchange, mentorship and research collaboration, the partnership supports a new generation of clinicians and researchers fluent in modern regenerative therapies.

## The Only Accredited Centre of Its Kind in the UAE

The collaboration underscores Everlast’s position as the only accredited centre in the UAE recognised for scientific research within its specialty. It reinforces the institution’s commitment to academic excellence, clinical innovation and international educational and research standards — and it places Abu Dhabi as a hub for advanced medical science and regenerative therapy in the region.`
  },
  {
    id: 'blog-13',
    slug: 'isds-regenerative-dermatology-leadership',
    title: 'International Scientific Leadership in Regenerative Dermatology at the 44th ISDS Annual Meeting',
    excerpt: 'At the 44th Annual Meeting of the ISDS — International Society for Dermatologic & Aesthetic Surgery, in Abu Dhabi, Dr. Christeen Youssef delivered an international scientific lecture and hosted a specialised conference on advanced stem cell therapies and regenerative dermatology.',
    // TODO(date): the stage banner gives the meeting as 16–18 October 2025 at the
    // Hilton Yas Island; this is the opening day, not a confirmed lecture day.
    // Set the actual one if it is known — the sort order, the article meta line
    // and the sitemap all read this field.
    date: '16/10/2025',
    category: 'CONFERENCE',
    readTime: '3 min',
    image: isdsPodiumImage,
    // The podium frame runs beside the section on what was presented, and the
    // moderators frame beside the section on the exchange between them — each
    // next to the passage it is evidence for, alternating side down the page.
    figures: [
      {
        section: 'stem-cells-and-tissue-engineering-in-clinical-practice',
        image: isdsPodiumWideImage,
        side: 'right',
        alt: 'Dr. Christeen Youssef presenting at the ISDS podium in Abu Dhabi.',
      },
      {
        section: 'an-international-platform-for-exchange',
        image: isdsModeratorsImage,
        side: 'left',
        alt: 'Dr. Christeen Youssef conferring with a fellow moderator between sessions.',
      },
    ],
    // One frame left in the band, so it takes the full-width letterbox on its
    // own at the foot of the article.
    gallery: [isdsRecognitionImage],
    content: `In October 2025, Dr. Christeen Youssef delivered an international scientific lecture and hosted a specialised conference in collaboration with the ISDS — International Society for Dermatologic & Aesthetic Surgery — at the Hilton Yas Island in Abu Dhabi, on the latest advances in stem cell therapy and regenerative dermatology.

## Stem Cells and Tissue Engineering in Clinical Practice

Dr. Christeen presented a comprehensive account of the expanding role of stem cells and tissue engineering in modern clinical practice: in the management of chronic dermatological disease, autoimmune skin disorders, hair loss conditions, diabetic foot ulcers, burns and post-burn scarring.

She set out how regenerative medicine is transforming the traditional treatment paradigm — integrating cellular therapies, biomaterials and new protocols to improve tissue repair and long-term therapeutic outcome, rather than managing the presentation and accepting the result.

## An International Platform for Exchange

The conference gave leading dermatologists, aesthetic surgeons and researchers a platform for exchanging expertise, discussing emerging technology and examining evidence-based approaches in advanced dermatologic and aesthetic treatment. Dr. Christeen took part in the session on trending treatments in cell therapy and its regenerative medicine overview.

Through this high-level collaboration, Everlast Wellness Medical Center further strengthened its position as a research-driven institution committed to scientific excellence, international cooperation, and the advancement of innovative, patient-centred regenerative therapy — in the UAE and on a global scale.

## Education, Publication and Standardised Protocols

The event also underlined the importance of multidisciplinary collaboration in accelerating scientific progress within regenerative medicine. Dr. Christeen underscored the need for continuous medical education, structured research publication, and the development of standardised treatment protocols — which is what safety, efficacy and long-term patient benefit actually rest on.

The meeting reinforced Abu Dhabi’s growing role as a regional hub for advanced dermatological research and stem cell innovation, reflecting a shared vision of integrating academic excellence with clinical application to raise standards of care across the region.

## Translational Research and Responsible Governance

The conference further emphasised the strategic importance of building sustainable international research networks, and of partnership between academic institutions, clinical centres and industry. Dr. Christeen highlighted the necessity of translational research — turning laboratory discovery into clinically applicable therapy — as the only route to measurable patient impact.

She also stressed the role of ethical governance, regulatory alignment and quality assurance in advancing stem cell and regenerative treatment responsibly. Taken together, the engagement raised the level of professional dialogue and contributed to positioning Abu Dhabi as a forward-thinking centre for innovation in regenerative dermatology and advanced aesthetic medicine.`
  },
  {
    id: 'blog-2',
    slug: 'sabah-al-emarat-revolutionary-scarfree',
    title: 'Dr. Christeen on "Sabah Al Emarat": Revolutionary Scar-Free Burn Healing',
    excerpt: 'Dr. Christeen, owner of Everlast Wellness Medical Center, recently shared a groundbreaking advancement in burn scar treatment on the "Sabah Al Emarat" TV program. Discover how tissue bio-engineering is rewriting the lives of burn survivors.',
    date: '01/06/2025',
    category: 'MEDIA',
    readTime: '8 min',
    image: sabahAlEmaratImage,
    content: `Dr. Christeen, owner of Everlast Wellness Medical Center, recently shared a groundbreaking advancement in burn scar treatment on the "Sabah Al Emarat" TV program. Discover how tissue bio-engineering is rewriting the lives of burn survivors, offering renewed hope and confidence.

## Understanding Tissue Bio-Engineering for Burn Scars

Tissue bio-engineering represents a modern leap in regenerative medicine, leveraging the body's innate ability to regenerate and heal skin tissue. This technique stimulates natural skin regrowth by combining biological materials with components from the patient's body.

- It harnesses the body's own healing powers.
- It promotes faster and more complete recovery.
- Effective for treating diabetic foot ulcers.
- Patients experience improved mental health due to less pain and faster results.

## How Does Tissue Bioengineering Work?

Imagine your skin as a house that needs repair. Instead of using foreign materials, tissue bio-engineering uses the original "bricks" (skin cells) and "building supplies" (growth factors) from your body to rebuild.

- Growth factors regulate skin cell growth, preventing abnormal scar formation.
- Controlled lasers and biological scaffolds guide skin regeneration.
- The method restores skin layers, including collagen, nerves, and blood vessels.
- This creates flexible, natural-looking skin without restricting movement.

## Clinical Advantages of Bio-Tissue Engineering

The clinical benefits are immense:

- Reduced Risk of Infection: Less invasive means lower infection rates.
- Improved Mobility: Ideal for scars near joints or on the face.
- Shorter Treatment Times: Accelerates healing and recovery.
- Psychological Well-Being: Visible improvements uplift patient spirits.
- Cost-Effective: Minimizes hospital stays and the need for extensive care.

## Transformative Psychological and Social Impact

Burn survivors often struggle with trauma, isolation, and diminished self-esteem. Tissue engineering addresses not just the physical scars but also the emotional wounds.

Consider the story of "Yousef" (not his real name), who suffered severe chest scars and profound psychological distress. Through dedicated treatment sessions, he rediscovered hope and a desire to help others facing similar struggles.

## Economic Advantages

Compared to traditional methods, bio-tissue engineering is economically sound:

- Shorter hospital stays reduce costs.
- Fewer surgeries save money.
- Faster recovery means patients return to work sooner.
- It reduces the overall strain on healthcare resources.

## Practical Advice

- Tissue Bioengineering offers a revolutionary approach to scarless burn healing.
- Early treatment leads to better results, but older scars can also benefit.
- It is a safe, minimally invasive, and psychologically supportive treatment.
- Seek specialists familiar with advanced regenerative therapies.
- Follow treatment protocols closely for optimal outcomes.

## Frequently Asked Questions (FAQ)

### How is bio-tissue engineering different from traditional scar treatments?

Unlike traditional methods, bio-tissue engineering uses the patient's own cells and growth factors to regenerate skin naturally without surgery or skin grafts.

### Can bio-tissue engineering improve old burn scars?

Yes, this technique can improve scars regardless of age by softening and regenerating skin layers using nanotechnology.

### Is this approach effective for all types of burns?

It is effective for thermal, chemical, and radiation burns, restoring both the appearance and functionality of the skin.

### When is the best time to begin treatment after a burn?

Early intervention yields the best results, but treatment can still be effective for older scars.

### Can bio-tissue engineering restore movement affected by burn scars?

Yes, it can restore skin flexibility and joint function by regenerating natural tissue and reducing scar-related tightness.

### What are the psychological benefits of this treatment?

Patients often experience improved self-esteem, reduced trauma, and enhanced social integration due to better cosmetic results and faster healing.

### How does this treatment impact healthcare costs?

By reducing the need for surgeries, hospital stays, and extensive care, bio-tissue engineering helps lower costs for patients and the healthcare system.

### Are multiple treatment sessions required for optimal results?

Treatment is tailored to each patient's needs, often involving several sessions over a period of weeks or months for the best possible results.

You can watch the full episode through this link`
  },
  {
    id: 'blog-3',
    slug: 'svf-diabetic-foot-treatment',
    title: 'The Role of Stromal Vascular Fraction (SVF) in the Treatment of Diabetic Foot: A Promising Therapeutic Approach',
    excerpt: 'Based on Dr. Christeen\'s speech at the 16th Abu Dhabi Wound Care Conference (ADWCC) 2025. Discover how SVF therapy offers new hope for patients with diabetic foot ulcers, significantly increasing healing rates and helping avoid amputation.',
    date: '15/03/2025',
    category: 'CONFERENCE',
    readTime: '5 min',
    image: diabeticFootImage,
    // From the 63-patient study the talk is built on, quoted below.
    stats: [
      { value: '63', label: 'patients with chronic, non-healing ulcers' },
      { value: '51', label: 'achieved full wound closure within six months' },
      { value: '50', label: 'still fully healed at one year' },
      { value: '10cm²', label: 'wounds and larger responded positively' },
    ],
    content: `Based on Dr. Christeen's speech at the 16th Abu Dhabi Wound Care Conference (ADWCC) 2025, organized by the IWCG.

## Why Diabetic Foot Ulcers Deserve Serious Attention?

Diabetic foot ulcers are among the most serious complications for people with diabetes. These wounds are slow to heal due to poor blood flow and nerve damage, making them prone to infection, long hospital stays, and, in severe cases, amputation. Traditional treatments—like dressings, antibiotics, and debridement—often do not heal these ulcers quickly or completely, especially in chronic cases.

## What Is SVF (Stromal Vascular Fraction)?

Stromal Vascular Fraction (SVF) is a mixture of regenerative cells taken from a patient's own fat tissue. SVF contains:

- Mesenchymal stem cells (MSCs) that can become different cell types
- Growth factors that stimulate tissue repair
- Cytokines that regulate immune response
- Other healing-promoting cells

The collection and injection process is quick and minimally invasive. SVF is usually injected around the wound site to support healing.

## How SVF Heals Diabetic Foot Ulcers?

SVF works in several ways to encourage wound healing:

- **Promotes New Blood Vessels:** SVF stimulates angiogenesis (formation of new blood vessels), improving circulation to the wound, a critical factor for healing in diabetic patients.
- **Reduces Inflammation:** SVF contains immune cells that help reduce chronic inflammation, creating a better environment for healing.
- **Regenerates Tissue:** SVF activates skin cells, increases collagen production, and supports tissue regeneration, helping wounds close faster and stronger.
- **Enhances Oxygen and Nutrient Delivery:** Improved blood flow means better oxygen and nutrient delivery, which is essential for tissue repair.

## Clinical Evidence: What the Research Says

A major clinical study involving 63 patients with chronic, non-healing diabetic foot ulcers (all at risk of amputation) found that:

- 51 patients achieved full wound closure within 6 months.
- 8 more had at least 75% improvement.
- After one year, 50 maintained complete healing, and 4 showed over 85% closure.
- No serious side effects were reported, even in patients with large ulcers.
- Doppler ultrasound confirmed improved blood flow in treated areas.
- Even wounds over 10 cm² responded positively, showing that SVF works for various ulcer sizes.

These results indicate that SVF can be safely used to treat chronic diabetic foot ulcers, with evidence of efficacy and mechanisms of action that include vascular repair and angiogenesis.

## Why SVF Is a Game-Changer

- **Minimally Invasive:** Uses the patient's fat-derived cells, no surgery or artificial implants.
- **Time-Efficient:** SVF can be collected and injected in a single outpatient visit.
- **Safe and Practical:** Suitable for resource-limited settings; does not require hospitalization.
- **Targets the Root Cause:** SVF improves circulation and promotes regeneration, not just symptom relief.

## Key Takeaways for Patients and Caregivers

- SVF therapy is a safe and effective option for chronic, non-healing diabetic foot ulcers.
- It significantly increases healing rates and may help avoid amputation.
- SVF therapy is showing potential to become a new standard in diabetic foot care worldwide.

## Frequently Asked Questions (FAQ)

### What is SVF, and how is it collected?

SVF is a blend of healing cells taken from a small amount of the patient's fat. The fat is processed, and the SVF is reinjected around the wound to support healing.

### Is SVF therapy safe?

Yes. Clinical studies show SVF therapy is generally safe, with no serious side effects reported. Minor discomfort or swelling may occur at the injection site.

### How does SVF compare to traditional treatments?

SVF leads to faster and more complete healing, especially in patients who haven't responded to standard therapies.

### Who is a candidate for SVF therapy?

Patients with chronic or non-healing diabetic foot ulcers, especially those at risk of amputation, may benefit. Medical consultation is needed to confirm suitability.

### How is SVF administered for diabetic foot ulcers?

SVF is injected around the wound and sometimes along the arteries of the foot to promote healing and improve blood flow.

### Are there any risks or side effects with SVF therapy?

No major side effects have been reported in clinical studies. Minor risks, such as infection or discomfort at the injection site, are possible but rare.

### Can SVF therapy prevent amputation in diabetic foot patients?

Yes, studies suggest that SVF therapy can help prevent limb loss by promoting healing in wounds that would otherwise require amputation.

## A New Era in Diabetic Wound Healing

SVF therapy offers new hope to patients with diabetic foot ulcers. It is safe, minimally invasive, and backed by scientific evidence. As more clinics adopt this approach, SVF may soon become a standard treatment, helping more people heal and avoid amputation.`
  },
  {
    id: 'blog-4',
    slug: 'international-conference-journals',
    title: 'International Conference Journals',
    excerpt: 'Active member of the international healthcare community with a passion on furthering standards of excellence in Aesthetic Dermatology spearheading clinically proven and safe best practices. Dynamic mentor dedicated to influencing positive change.',
    date: '09/01/2024',
    category: 'CONFERENCE',
    readTime: '1 min',
    image: internationalConferenceImage,
    content: `Active member of the international healthcare community with a passion on furthering standards of excellence in Aesthetic Dermatology spearheading clinically proven and safe best practices. Dynamic mentor dedicated to influencing positive change as a peer adviser, consultant, and healthcare educator.`
  },
  {
    id: 'blog-5',
    slug: 'success-story-client-everlast',
    title: 'A Success Story: A Client of Everlast Wellness Medical Center',
    excerpt: 'An active member of the international healthcare community with a passion for furthering standards of excellence in Aesthetic Dermatology. Dynamic mentor dedicated to influencing positive change.',
    date: '01/06/2025',
    category: 'TESTIMONIAL',
    readTime: '1 min',
    image: successStoryImage,
    content: `An active member of the international healthcare community with a passion for furthering standards of excellence in Aesthetic Dermatology spearheading clinically proven and safe best practices. Dynamic mentor dedicated to influencing positive change as a peer adviser, consultant, and healthcare educator.

## Client Testimonial

An active member of the international healthcare community with a passion for furthering standards of excellence in Aesthetic Dermatology spearheading clinically proven and safe best practices. Dynamic mentor dedicated to influencing positive change as a peer adviser, consultant, and healthcare educator.

## Watch the Full Story

You can watch the full success story through this link: [https://www.youtube.com/watch?v=BAC-q8VhDQY](https://www.youtube.com/watch?v=BAC-q8VhDQY)`
  },
  {
    id: 'blog-6',
    slug: 'botulinum-neurotoxin-consensus',
    title: 'Dr. Christeen Youssef\'s Pioneering Work in Botulinum Neurotoxin Research Now on PubMed',
    excerpt: 'Consensus Statement on the Use of Botulinum Neurotoxin in the Middle East. A multinational group of ten key opinion leaders, experts in facial plastic surgery and dermatology, convened the Middle East Aesthetics Consensus Group.',
    date: '01/06/2025',
    category: 'RESEARCH',
    readTime: '8 min',
    image: botulinumResearchImage,
    content: `## Consensus Statement on the Use of Botulinum Neurotoxin in the Middle East

### Abstract

Background: Aesthetic minimally invasive procedures have become very popular and culturally acceptable among Middle Eastern populations. Botulinum neurotoxin type A (BoNTA) is a valuable treatment modality for many cosmetic as well as therapeutic indications. The presence of BoNTA in our toolkit has revolutionized the field of aesthetic medicine to the point where it is now one of the most commonly performed cosmetic procedures worldwide. This consensus considers popular on- and off-label BoNTA indications in the Middle East.

Methods: A multinational group of ten key opinion leaders, experts in facial plastic surgery and dermatology, convened the Middle East Aesthetics Consensus Group and reviewed the aesthetic applications of BoNTA. Recommendations and position statements were drafted based on the integration of the panel's clinical experience with published data, targeted to the practices implemented in the Middle Eastern and the global population.

Results: Guidance statements are presented covering Middle Eastern facial characteristics and beauty ideals, BoNTA characteristics, pre-operative counselling, treatment indications and anatomical considerations, off-label and special uses including high-dose recommendations, and post-treatment advice. Throughout, an evidence-based approach to selection of products and injection techniques is provided, supplemented by the experts' advice on injections dosages and placement.

Conclusion: This consensus reflects the knowledge and expertise of physicians practicing in the Middle East. The panel acknowledged the use of on-label indications and variability in the toxin formulations and immunogenicity and agreed upon a wide use of "off-label" indications.

Keywords: Middle East; aesthetic use; botulinum neurotoxin type A; consensus.

## References

- International Society of Aesthetic Plastic Surgery (ISAPS). ISAPS international survey on aesthetic/cosmetic procedures performed in 2019.
- The middle east population; 2022.
- Kashmar M, Alsufyani MA, Ghalamkarpour F, et al. Consensus opinions on facial beauty and implications for aesthetic treatment in Middle Eastern women. Plast Reconstr Surg Glob Open. 2019;7(4):e2220.
- Yutskovskaya Y, Gubanova E, Khrustaleva I, et al. IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations. Clin Cosmet Investig Dermatol. 2015;8:297–306.
- Sundaram H, Huang PH, Hsu NJ, et al. Aesthetic applications of botulinum toxin A in Asians: an international, multidisciplinary, pan-asian consensus. Plast Reconstr Surg Glob Open. 2016;4(12):e872.
- Sundaram H, Signorini M, Liew S, et al. Global aesthetics consensus: botulinum toxin type a–evidence-based review, emerging concepts, and consensus recommendations for aesthetic use. Plast Reconstr Surg. 2016;137(3):518e–529e.
- Farkas LG, Katic MJ, Forrest CR, et al. International anthropometric study of facial morphology in various ethnic groups/races. J Craniofac Surg. 2005;16(4):615–646.
- Al-Sebaei MO. The validity of three neo-classical facial canons in young adults originating from the Arabian Peninsula. Head Face Med. 2015;11(1):4.
- El Minawi H, El Saloussy Y, Sabry M, Wahdan W, El Sharkawy O. Facial anthropometry and analysis in Egyptian women. Plast Reconstr Surg Glob Open. 2022;10(5):e4333.
- Samizadeh S, De Boulle K. Botulinum neurotoxin formulations: overcoming the confusion. Clin Cosmet Investig Dermatol. 2018;11:273–287.
- Kerscher M, Roll S, Becker A, Wigger-Alberti W. Comparison of the spread of three botulinum toxin type A preparations. Arch Dermatol Res. 2012;304(2):155–161.
- Grein S, Mander GJ, Fink K. Stability of botulinum neurotoxin type A, devoid of complexing proteins. Botulinum J. 2011;2(1):49–58.
- Carr WW, Jain N, Sublett JW. Immunogenicity of botulinum toxin formulations: potential therapeutic implications. Adv Ther. 2021;38(10):5046–5064.
- Fathallah AM, Bankert RB, Balu-Iyer SV. Immunogenicity of subcutaneously administered therapeutic proteins–a mechanistic perspective. AAPS J. 2013;15(4):897–900.
- Bellows S, Jankovic J. Immunogenicity associated with botulinum toxin treatment. Toxins. 2019;11(9):491.
- Kerscher M, Wanitphakdeedecha R, Trindade de Almeida A, Maas C, Frevert J. IncobotulinumtoxinA: a highly purified and precisely manufactured botulinum neurotoxin type A. J Drugs Dermatol. 2019;18(1):52–57.
- Carey WD. Incorrect reconstitution of incobotulinumtoxinA leads to loss of neurotoxin. J Drugs Dermatol. 2014;13(6):735–738.
- Niamtu J. Neurotoxin waste from drawing product through the vial stopper. J Clin Aesthet Dermatol. 2014;7(6):33–37.
- Thomas JP, Siupsinskiene N. Frozen versus fresh reconstituted botox for laryngeal dystonia. Otolaryngol Head Neck Surg. 2006;135(2):204–208.
- Soares DJ, Dejoseph LM, Zuliani GF, Liebertz DJ, Patel VS. Impact of postreconstitution room temperature storage on the efficacy of incobotulinumtoxinA treatment. Dermatol Surg. 2015;41(6):712–717.
- Wright G, Lax A, Mehta SB. A review of the longevity of effect of botulinum toxin in wrinkle treatments. Br Dent J. 2018;224(4):255–260.
- Frevert J. Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products. Drugs R D. 2015;15(1):1–9.
- Carruthers A, Carruthers J, Cohen JL. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter? Dermatol Surg. 2007;33(1):S97–S104.
- Trindade De Almeida AR, Secco LC, Carruthers A. Higher dilution associated with higher diffusion and less efficacy. Dermatol Surg. 2011;37(H):1553–1565.
- Cohen JL, Ozog DM, Editors. Botulinum Toxins: Cosmetic and Clinical Applications. First ed. JohnWiley & Sons Ltd; 2017.
- Kaidbey KH, Agin PP, Sayre RM, Kligman AM. Photoprotection by melanin, a comparison of black and Caucasian skin. J Am Acad Dermatol. 1979;1(3):249–260.
- Yi KH, Lee JH, Hu HW, Kim HJ. Anatomical proposal for botulinum neurotoxin injection for glabellar frown lines. Toxins. 2022;14(4):268.
- Amiri L, Galadari H, Al Mugaddam F, Souid AK, Stip E, Javaid SF. Perception of cosmetic procedures among Middle Eastern Youth. J Clin Aesthet Dermatol. 2021;14(12):E74–E83.
- Yi KY, Lee JH, Lee K, Hu HW, Lee HJ, Kim HJ. Novel anatomical proposal for botulinum neurotoxin injection targeting the platysma muscle. Toxins. 2022;14(12):868.
- Phan K, Younessi S, Dubin D, Lin MJ, Khorasani H. Emerging off-label esthetic uses of botulinum toxin in dermatology. Dermatol Ther. 2022;35(1):e15205.
- Yi KH, Lee JH, Hu HW, et al. Novel anatomical guidelines for botulinum neurotoxin injection for wrinkles in the nose region. Toxins. 2022;14(5):342.
- Yi KH, Lee JH, Hu HW, Kim HJ. Novel anatomical guidelines on botulinum neurotoxin injection in the mentalis muscle: a review. Anat Cell Biol. 2023;56(3):293–298.
- Yi KH, Lee JH, Hu HW, et al. Novel anatomical proposal for botulinum neurotoxin injection targeting depressor anguli oris for treating drooping mouth corner. Anat Cell Biol. 2023;56(2):161–165.
- Kaufman-Janette J, Cox SE, Dayan S, Joseph J. Botulinum toxin type a for glabellar frown lines: what impact of higher doses on outcomes? Toxins. 2021;13(7):494.
- Dayan S, Joseph J, Moradi A, et al. Subject satisfaction and psychological well-being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines. J Cosmet Dermatol. 2022;21(6):2407–2416.
- Fabi SG, Carruthers J, Joseph J, et al. High-dose neuromodulators: a roundtable on making sense of the data in real-world clinical practice. Aesthet Surg J Open Forum. 2021;3(4):ojab036.`
  },
  {
    id: 'blog-7',
    slug: 'advance-thread-lifting-techniques',
    title: 'Dr.Christeen Youssef – Advance Thread Lifting Techniques',
    excerpt: 'Active member of the international healthcare community with a passion on furthering standards of excellence in Aesthetic Dermatology spearheading clinically proven and safe best practices.',
    date: '01/06/2025',
    category: 'CONFERENCE',
    readTime: '1 min',
    image: advanceThreadImage,
    content: `Active member of the international healthcare community with a passion on furthering standards of excellence in Aesthetic Dermatology spearheading clinically proven and safe best practices. Dynamic mentor dedicated to influencing positive change as a peer adviser, consultant, and healthcare educator.`
  },
  {
    id: 'blog-8',
    slug: 'hands-on-laser-ebd-teaching-courses',
    title: 'Exploring the Exciting Sessions of Hands-On Laser and EBD Teaching Courses',
    excerpt: 'Hands-on laser and EBD teaching courses offer participants a unique opportunity to delve into the world of laser technology and evidence-based design principles.',
    date: '08/01/2024',
    category: 'WORKSHOP',
    readTime: '4 min',
    image: ebdTeachingImage,
    gallery: [ebdTeachingImage2, ebdTeachingImage3],
    content: `## Introduction

Hands-on laser and EBD (Evidence-Based Design) teaching courses offer participants a unique opportunity to delve into the world of laser technology and evidence-based design principles. In this blog post, we will explore some of the exciting sessions that are typically included in these courses. From laser tissue interaction energy-based devices, these sessions provide valuable insights and practical skills that enable educators to enhance their teaching methodologies and create optimal learning environments.

## Laser Tissue Interaction

Understanding the fundamental principles of laser tissue interaction is crucial for utilizing laser technology effectively. In this session, participants learn about the interaction between lasers and various types of tissues. They explore topics such as laser absorption, scattering, and thermal effects on different tissue structures. By gaining insights into laser tissue interaction, educators can better comprehend the applications and limitations of laser technology in medical, cosmetic, and research fields.

## Laser Safety

Laser safety is of paramount importance when working with such powerful and versatile technology. In this session, participants are trained in laser safety protocols, emphasizing the importance of proper handling, maintenance, and protective measures. They learn about laser classifications, personal protective equipment (PPE), and safety guidelines to ensure a secure working environment. This knowledge enables educators to prioritize the safety of themselves and their students when incorporating lasers into their teaching.

## Photo Thermolysis

Photo thermolysis is a key concept in laser technology that involves selective destruction of specific target tissues using laser energy. This session focuses on the principles and applications of photo thermolysis in various dermatological and medical procedures. Participants gain insights into the different types of lasers used for specific treatments and understand the factors influencing treatment parameters such as Florence, pulse duration, and spot size. This knowledge equips educators to discuss and teach the applications of photo thermolysis effectively.

## Laser Hair Removal

Laser hair removal is one of the most widely recognized applications of laser technology in the cosmetic field. In this session, participants learn about the science behind laser hair removal, including the targeting of melanin in hair follicles for selective destruction. They explore different laser systems and techniques employed for hair removal, as well as pre- and post-treatment care. Educators can incorporate this knowledge to introduce the concepts and process of laser hair removal to students interested in dermatology or cosmetic procedures.

## Vascular Lesions, Pigmented Lesions, and Rejuvenation

This session focuses on the treatment of vascular and pigmented lesions, as well as skin rejuvenation using laser technology. Participants learn about the principles of selective photo thermolysis and the specific lasers used for these treatments. They explore various types of vascular and pigmented lesions, such as port-wine stains, hemangiomas, age spots, and melasma. Educators can gain valuable insights to teach students about the applications, benefits, and limitations of laser treatments for these conditions.

## Energy-Based Devices

In addition to lasers, energy-based devices (EBDs) play a significant role in medical and cosmetic treatments. This session introduces participants to different types of EBDs, such as radio frequency, intense pulsed light (IPL), and ultrasound devices. They explore the principles of energy-based treatments, including skin tightening, body contouring, and non-invasive rejuvenation. Educators can incorporate this knowledge to broaden students' understanding of alternative energy-based modalities in the field of aesthetics and dermatology.

## Conclusion

Hands-on laser and EBD teaching courses offer a wide range of sessions that equip educators with valuable knowledge and practical skills. From understanding laser tissue interaction to exploring various applications such as laser hair removal, vascular lesions, pigmented lesions, and rejuvenation, these courses empower educators to incorporate laser technology and evidence-based design principles into their teaching methodologies. By embracing these innovative approaches, educators can create engaging learning experiences and inspire students to explore the fascinating world of laser technology and energy-based devices.`
  }
];
